Abstract
Toxoplasmosis, caused by the protozoan Toxoplasma gondii, poses a global threat, affecting approximately one-third of the world's population. While often asymptomatic, the infection can be fatal, particularly in immunocompromised individuals, leading to toxoplasmic encephalitis. The current treatment, based on pyrimethamine and sulfadiazine, exhibits limited efficacy and issues related to…